Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Price : Single User: US $ 4950  US $ 4208 Corporate User: US $ 14850  US $ 10395
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Crohn's disease for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Postmenopausal Vaginal Atrophy forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Postmenopausal Vaginal Atrophy till 2023.

Key Coverage and Benefits

  • The report will help in developing business strategies by understanding the trends shaping and driving the global Postmenopausal Vaginal Atrophy market.

  • Identifying patient populations in the global "Postmenopausal Vaginal Atrophymarket to improve product design, pricing, and launch plans.

  • Organize sales and marketing efforts by identifying the best opportunities for Postmenopausal Vaginal Atrophy therapeutics in each of the markets covered.

  • To understand the future market competition in the global Postmenopausal Vaginal Atrophy therapeutics market and Insightful review of the key market drivers and barriers.

Scope

  • Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.

  • Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

  • The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.

  • It also provides Postmenopausal Vaginal Atrophy for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Postmenopausal Vaginal Atrophy - Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Postmenopausal Vaginal Atrophy overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Postmenopausal Vaginal Atrophy Market
Global Epidemiology of Postmenopausal Vaginal Atrophy Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)
Market of Spain (2013-2015)
Forecasted Market of Spain (2016-2023)
Market of Japan (2013-2015)
Forecasted Market of Japan (2016-2023)
Market of ROW (2013-2015)
Forecasted Market of ROW (2016-2023)
Appendix
Report Methodology
Consulting Services
Disclaimer
Report Purchase Options
About DelveInsight

List of Tables

Table 1: Drug Description
Table 2: Drug, Marketed Details United States (US)
Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
Table 4: Drug, Patent Details for US
Table 5: Postmenopausal Vaginal Atrophy Drug Sales (USD Millions)-2023
Table 6: Global Epidemiology of Postmenopausal Vaginal Atrophy (2013-2023)
Table 7: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2013-2015)
Table 8: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2016-2023)
Table 9: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2013-2015)
Table 10: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2016-2023)
Table 11: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2013-2015)
Table 12: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2016-2023)
Table 13: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2013-2015)
Table 14: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2016-2023)
Table 15: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2013-2015)
Table 16: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2016-2023)
Table 17: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2013-2015)
Table 18: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2016-2023)
Table 19: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2013-2015)
Table 20: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2016-2023)
Table 21: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2013-2015)
Table 22: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2016-2023)
Table 23: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2013-2015)
Table 24: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2016-2023)

List of Figures

Figure 1: Postmenopausal Vaginal Atrophy Drug Sales (USD Millions)-2023
Figure 2: Global Epidemiology of Postmenopausal Vaginal Atrophy (2013-2023)
Figure 3: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2013-2015)
Figure 4: Postmenopausal Vaginal Atrophy Global Market (USD Millions), (2016-2023)
Figure 5: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2013-2015)
Figure 6: Postmenopausal Vaginal Atrophy US Market (USD Millions), (2016-2023)
Figure 7: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2013-2015)
Figure 8: Postmenopausal Vaginal Atrophy Germany Market (USD Millions), (2016-2023)
Figure 9: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2013-2015)
Figure 10: Postmenopausal Vaginal Atrophy United Kingdom Market (USD Millions), (2016-2023)
Figure 11: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2013-2015)
Figure 12: Postmenopausal Vaginal Atrophy France Market (USD Millions), (2016-2023)
Figure 13: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2013-2015)
Figure 14: Postmenopausal Vaginal Atrophy Italy Market (USD Millions), (2016-2023)
Figure 15: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2013-2015)
Figure 16: Postmenopausal Vaginal Atrophy Spain Market (USD Millions), (2016-2023)
Figure 17: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2013-2015)
Figure 18: Postmenopausal Vaginal Atrophy Japan Market (USD Millions), (2015-2023)
Figure 19: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2013-2015)
Figure 20: Postmenopausal Vaginal Atrophy ROW Market (USD Millions), (2016-2023)

  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • EMEA (Europe, Middle East and Africa) Contraceptives Market Report 2017
    Published: 23-Jun-2017        Price: US 4000 Onwards        Pages: 103
    In this report, the EMEA Contraceptives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Contraceptives for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux; - Mi......
  • Global Topical Contraceptive Market Professional Survey Report 2017
    Published: 22-Jun-2017        Price: US 3500 Onwards        Pages: 126
    This report studies Topical Contraceptive in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Pfizer - Merck Millipore - Allergan - Mylan - Teva Phar......
  • Asia-Pacific Topical Contraceptive Market Report 2017
    Published: 16-Jun-2017        Price: US 4000 Onwards        Pages: 122
    In this report, the Asia-Pacific Topical Contraceptive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Topical Contraceptive for these regions, from 2012 to 2022 (forecast), including - China - Japan - South Korea......
  • United States Contraceptives Market Report 2017
    Published: 16-Jun-2017        Price: US 3800 Onwards        Pages: 104
    In this report, the United States Contraceptives market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth r......
  • United States Bacterial Vaginosis Drug Market by Manufacturers, States, Type and Application, Forecast to 2022
    Published: 14-Jun-2017        Price: US 4480 Onwards        Pages: 117
    This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. Scope of the Report: This report focuses on the Bacterial Vaginosis Drug in United States market, to split the market based on manufacturers, states, type and application. Market Segment by Manufact......
  • Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2017
    Published: 13-Jun-2017        Price: US 2000 Onwards        Pages: 42
    Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Atrophy (Atrophic Vaginitis) - Pipeline Review, H1 2017, provides an overview of the Vaginal Atrophy (Atrophic Vaginitis) (Women's Health) pipeline landscape. Vaginal atrophy is thinning, drying and inflammation of the vaginal walls due to body having less estrogen. Signs and symptoms include......
  • Global Menopausal Hot Flashes Market 2017-2021
    Published: 24-May-2017        Price: US 3500 Onwards        Pages: 70
    Menopausal hot flashes are the symptoms of menopause. They refer to feelings of warmth occurring during menopause transition (which includes stages such as premenopause, perimenopause, and postmenopause). Hot flashes cause redness of the skin (known as flushing) and excessive sweating. The menopausal hot flashes market is growing moderately at the rate of 3.01% owing to the increase in aging population globally, especially in Western countries, such as the US, which is likely to increase the ......
  • Global Topical Contraceptive Market 2017-2021
    Published: 24-May-2017        Price: US 3500 Onwards        Pages: 70
    Topical contraceptives are contraceptive patches that release hormones, estrogen, and progestin to prevent pregnancies. They work in a similar manner as oral contraceptives. Various temporary and permanent contraceptive methods and devices for women are available in the market. Permanent methods such as sterilization are considered the most effective as they eliminate the chances of pregnancy. The analysts forecast global topical contraceptive market to grow at a CAGR of 2% during the......
  • Women's Health Cluster Drug Development Pipeline Review, 2017
    Published: 10-May-2017        Price: US 3995 Onwards        Pages: 123
    Women's Health Cluster Drug Development Pipeline Review, 2017 Summary This report provides an overview of the women's health pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for female infertility, polycystic ovarian syndrome and endometriosis, and also features dormant and discontinued projects. Infertility is defined as the inability to get pregnant after a year......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs